Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of hypotension during spinal anaesthesia for elective caesarean section
ACTRN12624001235594Phase 3Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron in hypotension (3 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoints: Incidence of hypotension from intrathecal drug administration until delivery and Overall administration of vasoactive drugs during spinal anaesthesia. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
hypotension
Beyond the preview
Go deeper on ACTRN12624001235594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001235594.